X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 20/12/2024 12:25

Shiitake-based supplement may help prevent liver damage progression

AHCC demonstrates potential in preventing liver fibrosis progression by inhibiting HSC activation and regulating key pathways involved in liver injury.

Articles similaires

Can a Headset Reduce Brain Injury and CTE in Football?

medindia.net - 25/Jan 13:45

A light-based headset may help protect football players from brain injury and traumatic encephalopathy (CTE) by reducing hidden inflammation from...

Eating less protein may help slow liver cancer

knowridge.com - 30/Jan 11:20

their risk of liver cancer—or slow its growth—by simply eating less protein. The research, published in the journal Science Advances, showed that...

Berberine does not reduce belly or liver fat, study finds

knowridge.com - 30/Jan 00:34

A new study has found that taking berberine, a plant-based supplement, for six months did not reduce belly fat or liver fat in people with obesity but...

Berberine does not reduce belly or liver fat, study finds

knowridge.com - 30/Jan 00:34

A new study has found that taking berberine, a plant-based supplement, for six months did not reduce belly fat or liver fat in people with obesity but...

Achieving Net Zero: The Environmental Impact of Diabetes Care

medindia.net - 24/Jan 13:53

Managing type 2 diabetes may help reduce COsub2/sub emissions by 21% via the healthcare system. Preventing diabetes progression lowers the impact of...

Sorry! Image not available at this time

Dr. Tommy Rhee Introduces a New Paradigm for Health and Longevity in The End of ...

wn.com - 22:09

In his newly released book, The End of Exercise and the Beginning of Activation, Dr. Tommy Rhee presents a science-backed challenge to conventional...

Towards better traffic management systems

newsday.co.tt - 21/Jan 10:16

DR STEPHEN RAMROOP THE COUNTRY is not ready for a major disaster or hazard impact. Recently, I asked a rhetorical question, “Are we ready for a...

Towards better traffic management systems

newsday.co.tt - 21/Jan 10:16

DR STEPHEN RAMROOP THE COUNTRY is not ready for a major disaster or hazard impact. Recently, I asked a rhetorical question, “Are we ready for a...

NuSHs can be a promising therapeutic strategy for preventing MASH-related hepatocellular carcinoma

news.medical.net - 21/Jan 16:16

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH),...

Why Targeting the Caspase-2 Enzyme is a Recipe for Liver Cancer

medindia.net - 20/Jan 09:26

Blocking Caspase-2 (the liver's guardian enzyme) to treat fatty liver may produce chronic damage and multiply the risk of liver cancer as we age.